Integrative Physiology |
From the Department of Pharmacology and Toxicology (J.T.E., M.M.H., G.J.G., J.E.B.), Division of Pediatric Surgery (J.E.B.), Medical College of Wisconsin, Milwaukee, Wis.
Correspondence to Janis T. Eells, PhD, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226. E-mail jeells{at}mcw.edu
| Abstract |
|---|
|
|
|---|
Key Words: chronic hypoxia 5-hydroxydecanoate mitochondrial KATP channel
| Introduction |
|---|
|
|
|---|
The precise cellular location at which the KATP channel mediates cardioprotection is unknown. If this can be identified, then the mechanisms through which KATP channels exert their protective effect may be determined. The cardioprotective effect of KATP channel openers, used at concentrations that do not shorten action potential duration, are abolished by the KATP channel blocker 5-hydroxydecanoate (5-HD).4 Thus, 5-HD does not appear to act on the sarcolemmal KATP channel. KATP channels are also found in the inner mitochondrial membrane5 6 where they control mitochondrial volume.7 8 However, it is unknown if this KATP channel is involved in mitochondrial energy production.9 Diazoxide, a KATP channel opener, is 1000 times more selective for opening mitochondrial KATP channels than sarcolemmal channels.7 The cardioprotective effect of diazoxide during ischemia is abolished by 5-HD, suggesting a role for the mitochondrial KATP channel in protection of the ischemic myocardium.10 5-HD abolished the cardioprotective effects of preconditioning in immature hearts, suggesting a cardioprotective role for mitochondrial KATP channels in immature hearts during conditions of oxygen deprivation.3
The present study further explores the involvement of mitochondria in the adaptation of heart muscle to chronic hypoxia. We hypothesize that activation of the mitochondrial KATP channel and its impact on mitochondrial bioenergetics may be an important event associated with increased resistance to ischemia in hearts adapted to chronic hypoxia. To assess the contribution of mitochondrial KATP channels, the rate of mitochondrial ATP synthesis was compared in normoxic and chronically hypoxic hearts. Our findings indicate that acute activation of the mitochondrial KATP channel increases K+ influx into mitochondria, resulting in a reduction in the driving force for ATP synthesis. In addition, these findings indicate that KATP channels are tonically active in mitochondria isolated from hypoxic hearts and that this tonic activity may play a role in the alteration of mitochondrial bioenergetics, which renders the hypoxic heart more resistant to myocardial ischemia.
| Materials and Methods |
|---|
|
|
|---|
Assessment of Ventricular Function
The isolated rabbit heart model was used for these
studies and was instrumented as previously
described.2 11
The standard perfusate used was Krebs-Henseleit bicarbonate
buffer.12
Immediately after aortic cannulation, hearts were perfused at a
constant pressure of 43 mm Hg in the Langendorff mode for 30 minutes,
during which time balloons were placed in both the left and right
ventricles. Biventricular function and coronary flow rate were then
recorded under steady-state
conditions.2 3
Hearts were then perfused with either a KATP
opener (bimakalim, 1 µmol/L) or a KATP blocker
(glibenclamide, 1 µmol/L, or 5-HD, 300 µmol/L) for another 15
minutes before a 30-minute period of global, no-flow ischemia at
39°C. After the ischemic period, hearts were reperfused for 35
minutes, during which time the various indexes of cardiac function were
again measured under steady-state conditions. Thus, each heart served
as its own control.
Mitochondrial ATP Synthesis, Membrane
Potential, and Ventricular ATP Concentrations
Mitochondria were isolated from normoxic and hypoxic
hearts by differential centrifugation as described by Solem and
Wallace.13 Cardiac
mitochondria prepared by this methodology have been shown to be
metabolically active with respiratory control ratios of 3.5 to 5.0 with
succinate and 8.0 to 10.0 with glutamate/malate and corresponding
ADP/O2 ratios of 1.5 to 1.7 and 2.5 to 2.7.
Mitochondrial ATP synthesis was measured in the presence of complex I
substrates (pyruvate plus malate) as previously
described.14
Semiquantitative measurements of the potential difference across the
inner mitochondrial membrane were determined spectrofluorometrically
using the dye
rhodamine-123.15 ATP
concentrations were determined in ventricular tissue extracts by
luciferin-luciferase
luminometry.14 16 17
Statistical Analysis
Recovery of developed pressure was expressed as a
percentage of its predrug value. A minimum of 6 hearts was used for
each of the 10 conditions studied, and the results are expressed as
mean±SD or mean±SE. Statistical analysis was performed by use of
repeated-measures ANOVA, with the Greenhouse-Geisser adjustment used to
correct for the inflated risk of a type I
error.18 After
ANOVA, the data were corrected for multiple comparisons. Significance
was accepted at a level of
P<0.05.
| Results |
|---|
|
|
|---|
|
|
Effect of Chronic Hypoxia on Mitochondrial ATP
Synthesis and Myocardial Energy Metabolism
ATP synthesis was measured in mitochondria
isolated from hearts of normoxic and chronically hypoxic rabbits in the
presence of the complex I substrates pyruvate and
malate.14 16 17
As shown in
Figure 2
, the rate of ATP synthesis in cardiac mitochondria
was linear for 10 to 12 minutes in mitochondria isolated from both
normoxic and hypoxic rabbits. The rate of ATP production in hypoxic
heart mitochondria (3.82±0.23 µmol ATP ·
min-1 · mg mitochondrial
protein-1) was significantly greater than
the rate of ATP production in normoxic heart mitochondria (2.95±0.08
µmol ATP · min-1 · mg mitochondrial
protein-1). ATP concentrations before the
addition of respiratory substrates were 63±4 µmol/mg of
mitochondrial protein in normoxic heart mitochondria and 73±12
µmol/mg in hypoxic heart mitochondria.
|
Other differences in myocardial energy metabolism were also
apparent in chronically hypoxic versus normoxic immature rabbit hearts.
Table 2
shows that ventricular lactate concentrations were
twice as high in hypoxic hearts than normoxic hearts and ventricular
lactate dehydrogenase (LDH) concentrations were 35% greater in hypoxic
than normoxic hearts. In addition, we have previously reported a shift
in the LDH isoform distribution toward the M or LD5 isoform in hypoxic
hearts.2 These
changes are indicative of an increased dependency on anaerobic
glycolysis for energy production in hypoxic hearts. The combination of
increased mitochondrial ATP production and increased glycolytic ATP
production is likely to be responsible for the observation that
myocardial ATP concentrations did not differ between normoxic and
hypoxic hearts
(Table 2
).
|
KATP
ChannelMediated Alterations in Mitochondrial ATP Synthesis
Activation of the mitochondrial
KATP channel has been shown to increase
K+ influx into the mitochondrial matrix,
resulting in mitochondrial membrane depolarization and a reduction in
the driving force for ATP
synthesis.5 8 10
The effects of KATP channel openers and blockers
on ATP synthesis in mitochondria isolated from normoxic rabbit hearts
are shown in
Figures 3
and 4
. As shown in
Figure 3
, the KATP channel opener
bimakalim inhibited the rate of ATP synthesis in mitochondria isolated
from normoxic rabbit hearts. In the presence of 1 µmol/L bimakalim,
the rate of ATP synthesis was reduced from 2.96±0.10 µmol
ATP · min-1 · mg mitochondrial
protein-1 to 1.56±0.22 µmol
ATP · min-1 · mg mitochondrial
protein-1, a 52% reduction in the rate of
ATP synthesis. The inhibitory action of bimakalim on mitochondrial ATP
synthesis was sensitive to the KATP channel
blocker glibenclamide (1 µmol/L). Glibenclamide (1 µmol/L) alone
had no effect on the rate of ATP synthesis in normoxic heart
mitochondria. However, the addition of glibenclamide (1 µmol/L)
before the addition of bimakalim prevented the inhibition of ATP
synthesis mediated by bimakalim.
Figure 3
also shows that the reduction in ATP synthesis
mediated by bimakalim (1 µmol/L) was abolished by the mitochondrial
selective KATP blocker 5-HD (300 µmol/L). As
with glibenclamide, 5-HD alone had no effect on the rate of
mitochondrial ATP synthesis but prevented the reduction of ATP
synthesis mediated by bimakalim.
|
|
Data presented in
Figure 4
show that the mitochondria-specific
KATP channel opener diazoxide (100 µmol/L)
also reduced the rate of ATP synthesis from 3.04±0.30 µmol
ATP · min-1 · mg mitochondrial
protein-1 to 2.03±0.30 µmol ATP ·
min-1 · mg mitochondrial
protein-1, a 32% reduction in the rate of
ATP synthesis. Furthermore, in nominally
K+-free medium, diazoxide (100 µmol/L) had
no effect on the rate of mitochondrial ATP synthesis indicating that
the effect of KATP channel openers on
mitochondrial ATP synthesis is dependent on the electrochemical
gradient for K+. The reduced rates of
mitochondrial ATP synthesis measured in nominally
K+-free medium are likely due to an increase
in K+-H+ antiport
activity.7 8
Although it is possible that a reduction in ATP synthesis might
interfere with the action of KATP channel
openers, the similarity of our findings with other studies
demonstrating that the effects of KATP channel
openers on mitochondrial membrane potential and mitochondrial swelling
are dependent on the electrochemical gradient for
K+ support this
interpretation.8 9
Effects of KATP
Channel Openers and Blockers on ATP Synthesis in Mitochondria Isolated
From Normoxic and Chronically Hypoxic Hearts
Figure 5A
compares the effect of bimakalim on mitochondrial
ATP synthesis in normoxic and hypoxic heart mitochondria. In
mitochondria isolated from normoxic hearts, bimakalim produced a
concentration-dependent decrease in the rate of ATP synthesis, reducing
the rate of synthesis 50% at 1 µmol/L and 60% at 10 µmol/L. The
rate of ATP synthesis in hypoxic heart mitochondria was not affected by
the KATP channel opener bimakalim at
concentrations of 1 or 10 µmol/L.
Figure 5B
compares the effect of the
KATP blockers glibenclamide (1 µmol/L) and
5-HD (300 µmol/L) on mitochondrial ATP synthesis in mitochondria
isolated from normoxic and chronically hypoxic immature rabbit hearts.
Neither KATP blocker altered the rate of ATP
synthesis in normoxic heart mitochondria; however, in hypoxic heart
mitochondria, both glibenclamide and 5-HD significantly reduced the
rate of ATP synthesis. Glibenclamide produced a 50% decrease in the
rate of ATP synthesis and 5-HD reduced ATP synthesis by
25%.
|
Mitochondrial Membrane Potential in
Mitochondria Isolated From Normoxic and Chronically Hypoxic
Hearts
Semiquantitative measurements of mitochondrial membrane
potential were determined using the fluorescent probe
rhodamine-123.15 In
the absence of KATP channel modulators, resting
membrane potential was remarkably similar in mitochondria isolated from
normoxic and hypoxic hearts. Isolated cardiac mitochondria have been
reported to have a membrane potential of -180±15 mV in studies using
the potential sensitive probe
tetraphenylphosphonium.9
Attempts to assess the effects of KATP channel
openers or blockers in mitochondria isolated from normoxic and hypoxic
hearts using rhodamine-123 were confounded by interactions between the
vehicle or the drugs and the fluorescent
probe.
| Discussion |
|---|
|
|
|---|
In light of recent studies implicating the mitochondrial KATP channel in cardioprotection,10 18 19 20 21 22 23 24 we conducted experiments to examine the role of the mitochondrial KATP channel in adaptation to chronic hypoxia in immature hearts. To assess mitochondrial KATP channel function, we measured the effect of several KATP channel openers and blockers on mitochondrial ATP synthesis in metabolically active mitochondria isolated from hearts of normoxic and chronically hypoxic rabbits. This approach was predicated on the knowledge that activation of the mitochondrial KATP channel has been shown to increase the influx of K+ into mitochondria, resulting in mitochondrial depolarization and a reduction in the rate of ATP synthesis.9 The actions of KATP channel openers and blockers in mitochondria isolated from normoxic and hypoxic hearts paralleled their actions on cardiac function in isolated perfused hearts. KATP channel activation by bimakalim resulted in a decrease in the rate of ATP synthesis in normoxic heart mitochondria but had no effect on ATP synthesis in hypoxic heart mitochondria. Similarly, KATP channel activation markedly enhanced recovery of ventricular function in normoxic hearts but had no effect on functional recovery in hypoxic hearts. In normoxic heart mitochondria, the KATP blockers glibenclamide and 5-HD had no effect on the rate of ATP synthesis, suggesting that mitochondrial KATP channels are not tonically active. These blockers also had no effect on recovery of function in normoxic hearts. In contrast, in hypoxic heart mitochondria, KATP channel blockers reduced the rates of ATP synthesis to rates similar to those observed in normoxic heart mitochondria. In hypoxic hearts, both KATP blockers significantly attenuated cardioprotection. These results corroborate our previous findings in isolated perfused hearts1 2 3 and strongly suggest that enhanced activation of the mitochondrial KATP channel is an important component of the cardioprotective mechanisms involved in adaptation to hypoxic stress.
A second significant finding of these studies was the increased rate of ATP synthesis observed in mitochondria isolated from chronically hypoxic hearts. Moreover, there was no difference in myocardial ATP concentrations or in mitochondrial membrane potential in hypoxic versus normoxic hearts. One potential explanation for the apparent discrepancy between the inhibition of the rate of ATP synthesis observed in mitochondria isolated from normoxic immature rabbit hearts versus the enhanced rate of ATP synthesis after chronic hypoxia may be due to differences between acute versus chronic activation of the mitochondrial KATP channel. In the acute situation (ie, mitochondria isolated from normoxic hearts), activation of the mitochondrial KATP channel by KATP channel openers results in K+ influx into mitochondria, mitochondrial depolarization, and a reduction in the driving force for ATP production measured in the present studies as a reduction in the rate of ATP synthesis. Our data further indicate that chronic hypoxia produces a tonic activation of the mitochondrial KATP channel. This is likely to result in adaptive changes in mitochondrial physiology. The observation that resting mitochondrial membrane potential did not differ between mitochondria isolated from normoxic or hypoxic hearts provides further evidence of an adaptive response to tonic activation of the mitochondrial KATP channel. Other studies have provided evidence that mitochondrial bioenergetics and metabolism are fundamentally altered by chronic hypoxia with changes reported in mitochondrial creatine kinase activity and in the ADP and O2 dependence of mitochondrial respiration.25 26 Our findings suggest that an alteration in mitochondrial KATP channel function may be another component in mitochondrial adaptation to hypoxia. Recent studies showing involvement of the mitochondrial KATP channel in adaptation to high-altitude hypoxia further support this interpretation.27
Taken together, our findings suggest that the cardioprotective effects of mitochondrial KATP channel activation may be linked to improved oxidative metabolism and mitochondrial bioenergetics. An important role of the mitochondrial KATP channel is to regulate mitochondrial volume, which in turn is thought to regulate electron transport and bioenergetics.5 7 8 9 10 Opening of the mitochondrial KATP channel has been shown to shift the balance between K+ uniport and K+-H+ antiport, resulting in transient net K+ uptake and increased matrix volume.5 8 Halestrap7 has established that small increases in matrix volume stimulate electron transport and that activation of the mitochondrial KATP channel may trigger this response. Mitochondrial KATP channel activation may therefore be an essential component of a signal transduction pathway calling for increased ATP production to support increased work in the heart or possibly to compensate for decreased oxygen availability. Conversely, blockade of the mitochondrial KATP channel may interfere with the cellular or mitochondrial response to these signals. The reduction in the rate of ATP synthesis observed in mitochondria from hypoxic hearts treated with KATP channel blockers is consistent with this interpretation.
We have suggested that adaptation to chronic hypoxia represents a unique form of preconditioning, and we have recently supported this contention by showing that although immature normoxic hearts can be preconditioned, immature hypoxic hearts cannot be preconditioned.3 Furthermore, we have shown that the mechanism of preconditioning in the immature normoxic heart is associated with KATP channel activation and is abolished by the mitochondrial KATP channel blocker 5-HD.1 2 Although a direct link between mitochondrial KATP channel activation and myocardial protection remains to be established, several known consequences of mitochondrial KATP channel activation are likely to improve mitochondrial function after ischemia. Activation of the mitochondrial KATP channel results in K+ influx into mitochondria, expansion of mitochondrial matrix volume, and a reduction of the inner mitochondrial membrane potential established by the proton pump.5 6 7 8 9 10 Regulation of matrix volume is an essential element in the regulation of mitochondrial energy production, and matrix expansion secondary to mitochondrial KATP channel opening has been postulated to activate electron transport and stimulate mitochondrial metabolism.7 Our findings of increased rates of ATP synthesis in mitochondria isolated from hypoxic hearts are consistent with this mechanism.
In summary, our data in conjunction with the studies of other investigators support a role for mitochondrial KATP channel activation and its impact on mitochondrial bioenergetics as an important factor in increased resistance to ischemia in hearts adapted to chronic hypoxia.
| Acknowledgments |
|---|
This work was supported by grants from National Heart, Lung, and Blood Institute (HL-08311 and HL-45048) and from the National Institute of Environmental Health Sciences (ES-06648). The authors wish to thank Patricia Holman for her excellent technical assistance.
Received July 26, 2000; revision received September 19, 2000; accepted September 19, 2000.
| References |
|---|
|
|
|---|
2.
Baker
JE, Curry BD, Olinger GN, Gross GJ. Increased tolerance of the
chronically hypoxic immature heart to ischemia: contribution of the
KATP channel. Circulation. 1997;95:12781285.
3.
Baker
JE, Holman P, Gross GJ. Preconditioning in immature rabbit hearts: role
of KATP channels. Circulation. 1999;99:12491254.
4.
McCullough
JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific
block of the anti-ischemic actions of cromakalim by sodium
5-hydroxy-decanoate. Circ Res. 1991;69:949958.
5.
Paucek
P, Mironova G, Mahdi F, Beavis AD, Woldegiorgis G, Garlid KD.
Reconstitution and partial purification of the glibenclamide-sensitive,
ATP-dependent K+ channel from rat liver and
beef heart mitochondria. J Biol Chem. 1992;267:2606226069.
6. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 1991;352:244247.[Medline] [Order article via Infotrieve]
7. Halestrap A. Regulation of mitochondrial metabolism through changes in matrix volume. Biochem Soc Trans. 1994;22:522529.[Medline] [Order article via Infotrieve]
8.
Garlid
KD, Paucek P, Yarov-Yarovoy V, Sun X, Schindler PA. The mitochondrial
KATP channel as a receptor for potassium channel
openers. J Biol Chem. 1996;271:87968799.
9.
Holmuhamedov
E, Jovanovic S, Dzeja P, Jovanovic A, Terzic A. Mitochondrial
ATP-sensitive K+ channels modulate cardiac
mitochondrial function. Am J Physiol. 1998;275:H1567H1576.
10.
Garlid
KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, DíAlonzo AJ,
Lodge NJ, Smith MA, Grover GJ. Cardioprotective effect of
diazoxide and its interaction with mitochondrial ATP-sensitive
K+ channels: potential mechanism of
cardioprotection. Circ Res. 1997;81:10721082.
11.
Baker
EJ, Boerboom LE, Olinger GN, Baker JE. Tolerance of the developing
heart to ischemia: impact of hypoxemia from birth. Am J
Physiol. 1995;268:H1165H1173.
12. Krebs HA, Henseleit K. Untersuchungen uber die Harstoffbidung im Tierkorper. Hoppe Seylers Z Physiol Chem. 1932;210:3366.
13. Solem L, Wallace K. Selective activation of the sodium-independent, cyclosporin A-sensitive calcium pore of cardiac mitochondria by doxorubicin. Toxicol Appl Pharmacol. 1993;121:50157.[Medline] [Order article via Infotrieve]
14.
Fryer
R, Eells J, Hsu A, Henry M, Gross G. Ischemic preconditioning in rats:
role for the mitochondrial KATP channel in the
preservation of mitochondrial function. Am J
Physiol. 2000;278:H305H312.
15. Emaus RK, Grunwald R, Lemasters JJ. Rhodamine-123 as a probe of transmembrane potential in isolated liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta. 1986;850:436448.
16. DiMonte D, Sandy M, Jewell S, Adornato B, Tanner C, Langston J. Oxidative phosphorylation by intact muscle mitochondria in Parkinsons disease. Neurodegeneration. 1993;2:275281.
17. Strehler B. Bioluminescence assay: principles and practice. Methods Biochem Anal. 1968;16:99181.[Medline] [Order article via Infotrieve]
18.
Ludbrook
J. Repeated measurements and multiple comparisons in cardiovascular
research. Cardiovasc Res. 1994;28:303311.
19.
Liu Y,
Sato T, ORourke B, Marbán E. Mitochondrial ATP-dependent potassium
channels: novel effectors of cardioprotection?
Circulation. 1998;97:24632469.
20.
Gross
G, Fryer R. Sarcolemmal versus mitochondrial ATP-sensitive
K+ channels and myocardial preconditioning.
Circ Res. 1999;84:973979.
21. DiLisa F, Manabo R, Canton M, Petronilli V. The role of mitochondria in the salvage and injury of the ischemic myocardium. Biochim Biophys Acta. 1998;1336:6978.
22. Ferrari R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol. 1996;28:S1S10.
23.
Takeo
S, Nasa Y. Role of energy metabolism in the preconditioned heart: a
possible contribution to mitochondria. Cardiovasc Res. 1999;43:3243.
24. Holmuhamedov E, Wang L, Terzic A. ATP-sensitive K+ channel openers prevent Ca 2+ overload in rat cardiac mitochondria. Am J Physiol. 1999;519:347360.
25. Novel-Chate V, Mateo P, Saks VA, Hoetrer JA, Rossi A. Chronic exposure of rats to hypoxic environment alters the mechanism of energy transfer in myocardium. J Mol Cell Cardiol. 1998;30:12951303.[Medline] [Order article via Infotrieve]
26.
Costa
LE, Mendez G, Boveris A. Oxygen dependence of mitochondrial function
measured by high resolution respirometry in long term hypoxic rats.
Am J Physiol. 1997;273:C852C858.
27. Asemu G, Papousek F, Ostadal B, Kolar F. Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias: involvement of mitochondrial KATP channel. J Mol Cell Cardiol. 1999;31:18211831.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
W. Zhang, F. R. Carreno, J. T. Cunningham, and S. W. Mifflin Chronic sustained and intermittent hypoxia reduce function of ATP-sensitive potassium channels in nucleus of the solitary tract Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1555 - R1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Gutsaeva, M. S. Carraway, H. B. Suliman, I. T. Demchenko, H. Shitara, H. Yonekawa, and C. A. Piantadosi Transient Hypoxia Stimulates Mitochondrial Biogenesis in Brain Subcortex by a Neuronal Nitric Oxide Synthase-Dependent Mechanism J. Neurosci., February 27, 2008; 28(9): 2015 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Watanabe, H. Yaoita, K. Ogawa, M. Oikawa, K. Maehara, and Y. Maruyama Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol Cardiovasc Res, August 1, 2006; 71(3): 537 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. La Padula and L. E. Costa Effect of sustained hypobaric hypoxia during maturation and aging on rat myocardium. I. Mechanical activity J Appl Physiol, June 1, 2005; 98(6): 2363 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neckar, I. Markova, F. Novak, O. Novakova, O. Szarszoi, B. Ost'adal, and F. Kolar Increased expression and altered subcellular distribution of PKC-{delta} in chronically hypoxic rat myocardium: involvement in cardioprotection Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1566 - H1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Milano, P. Bianciardi, A. F. Corno, E. Raddatz, S. Morel, L. K. von Segesser, and M. Samaja Myocardial Impairment in Chronic Hypoxia Is Abolished by Short Aeration Episodes: Involvement of K+ATP Channels Exp Biol Med, December 1, 2004; 229(11): 1196 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Rourke Evidence for Mitochondrial K+ Channels and Their Role in Cardioprotection Circ. Res., March 5, 2004; 94(4): 420 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Cameron, K. E. Hoffmann, C. Zia, H. M. Hemmett, A. Kronsteiner, and C. M. Lee A role for nitric oxide in hypoxia-induced activation of cardiac KATP channels in goldfish (Carassius auratus) J. Exp. Biol., November 15, 2003; 206(22): 4057 - 4065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Digerness, P. S. Brookes, S. P. Goldberg, C. R. Katholi, and W. L. Holman Modulation of mitochondrial adenosine triphosphate-sensitive potassium channels and sodium-hydrogen exchange provide additive protection from severe ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 863 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neckar, O. Szarszoi, L. Koten, F. Papousek, B. Ost'adal, G. J Grover, and F. Kolar Effects of mitochondrial KATP modulators on cardioprotection induced by chronic high altitude hypoxia in rats Cardiovasc Res, August 15, 2002; 55(3): 567 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, G. Milano, M. Samaja, P. Tozzi, and L. K. von Segesser Chronic hypoxia: A model for cyanotic congenital heart defects J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xi, D. Tekin, E. Gursoy, F. Salloum, J. E. Levasseur, and R. C. Kukreja Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H5 - H12. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. MacCormack and W. R. Driedzic Mitochondrial ATP-sensitive K+ channels influence force development and anoxic contractility in a flatfish, yellowtail flounder Limanda ferruginea, but not Atlantic cod Gadus morhua heart J. Exp. Biol., May 15, 2002; 205(10): 1411 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jayakumar, K. Suzuki, I. A. Sammut, R. T. Smolenski, M. Khan, N. Latif, H. Abunasra, B. Murtuza, M. Amrani, and M. H. Yacoub Heat Shock Protein 70 Gene Transfection Protects Mitochondrial and Ventricular Function Against Ischemia-Reperfusion Injury Circulation, September 18, 2001; 104 (2009): I-303 - I-307. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |